Cavan Redmond joined our Board of Directors in February 2018. Mr. Redmond previously served as Chief Executive Officer and member of the Board at WebMD Health Corp., where he streamlined operations to position the company for growth. Prior to that, Mr. Redmond served as Group President at Pfizer, Inc., where he was responsible for integrating and building a diverse business portfolio following the company’s merger with Wyeth. During his tenure at Pfizer, he was also responsible for Pfizer’s Corporate strategy. Additionally, Mr. Redmond held various positions at Wyeth including the 1st General Manager of Wyeth Biopharma, which he grew to become the 4th largest biotechnology company prior to the Pfizer acquisition. He also has significant consumer healthcare business experience overseeing both Wyeth Consumer Healthcare and Pfizer Consumer Healthcare. Mr. Redmond holds a BA from the University of Maryland and a Master of Administrative Sciences from Johns Hopkins University, which in 2012 honored him with a Distinguished Alumnus Award.